Scutellarin promotes in vitro angiogenesis in human umbilical vein endothelial cells

Biochemical and Biophysical Research Communications

Volumn 400, Issue 1, 2010, Pages 151-156

  Gao, Zhong Xiu Zi ^a   Huang, Da Yong ^a   Li, Hai Xia ^a   Zhang, Li Na ^a   Lv, Yan Hong ^a   Cui, Hai Dong ^a   Zheng, Jin Hua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Human umbilical vein endothelial cell; MMP 2; PECAM 1; Scutellarin

Indexed keywords

CD31 ANTIGEN; GELATINASE A; MATRIGEL; MESSENGER RNA; SCUTELLARIN; ANGIOGENIC FACTOR; APIGENIN; GLUCURONIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANGIOGENESIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; VASCULAR ENDOTHELIUM; WOUND HEALING; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; UMBILICAL VEIN;

ANGIOGENESIS INDUCING AGENTS; ANTIGENS, CD31; APIGENIN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GLUCURONIC ACIDS; HUMANS; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE INHIBITOR OF METALLOPROTEINASE-3; UMBILICAL VEINS; GLUCURONATES;

ERIGERON BREVISCAPUS;

EID: 79957957063     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.034     Document Type: Article

References (30)

1. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87:1153-1155.
2. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1:27-31.
4. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
5. Griffith L.G., Naughton G. Tissue engineering - current challenges and expanding opportunities. Science 2002, 295:1009-1014.
6. Emanueli C., Madeddu P. Changing the logic of therapeutic angiogenesis for ischemic disease. Trends Mol. Med. 2005, 11:207-216.
7. Timar J., Dome B., Fazekas K., Janovics A., Paku S. Angiogenesis-dependent diseases and angiogenesis therapy. Pathol. Oncol. Res. 2001, 7:85-94.
8. Shea L.D., Smiley E., Bonadio J., Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 1999, 17:551-554.
9. Hong H., Liu G.Q. Scutellarin protects PC12 cells from oxidative stress-induced apoptosis. J. Asian Nat. Prod. Res. 2007, 9:135-143.
10. Luo P., Tan Z.H., Zhang Z.F., Zhang H., Liu X.F., Mo Z.J. Scutellarin isolated from Erigeron multiradiatus inhibits high glucose-mediated vascular inflammation. Yakugaku Zasshi 2008, 128:1293-1299.
11. Pan Z., Feng T., Shan L., Cai B., Chu W., Niu H., Lu Y., Yang B. Scutellarin-induced endothelium-independent relaxation in rat aorta. Phytother. Res. 2008, 22:1428-1433.
12. Lin L.L., Liu A.J., Liu J.G., Yu X.H., Qin L.P., Su D.F. Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats. J. Cardiovasc. Pharmacol. 2007, 50:327-332.
13. Hu X.M., Zhou M.M., Zeng F.D. Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacol. Sin. 2005, 26:1454-1459.
14. Ma J.Y., Jiang W.W., Zhou Z.T., Li J.M., Wang H.Y. The promoting angiogenesis and anti-inflammation effect of scutellarin on polyglycolic acid scaffold of balb/c mice model. J. Asian Nat. Prod. Res. 2008, 10:1147-1153.
15. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003, 9:653-660.
16. Yang S., Graham J., Kahn J.W., Schwartz E.A., Gerritsen M.E. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am. J. Pathol. 1999, 155:887-895.
17. Ingber D. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J. Cell. Biochem. 1991, 47:236-241.
18. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
19. Moses M.A. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 1997, 15:180-189.
20. Brooks P.C., Silletti S., von Schalscha T.L., Friedlander M., Cheresh D.A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998, 92:391-400.
21. Hiraoka N., Allen E., Apel I.J., Gyetko M.R., Weiss S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998, 95:365-377.
22. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 1995, 270:5331-5338.
23. Hernandez-Barrantes S., Toth M., Bernardo M.M., Yurkova M., Gervasi D.C., Raz Y., Sang Q.A., Fridman R. Binding of active (57kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 2000, 275:12080-12089.
24. Seiki M. The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr. Opin. Cell Biol. 2002, 14:624-632.
25. Xia P., Aiello L.P., Ishii H., Jiang Z.Y., Park D.J., Robinson G.S., Takagi H., Newsome W.P., Jirousek M.R., King G.L. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest. 1996, 98:2018-2026.
26. Griner E.M., Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 2007, 7:281-294.
27. Harrington E.O., Loffler J., Nelson P.R., Kent K.C., Simons M., Ware J.A. Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells. J. Biol. Chem. 1997, 272:7390-7397.
28. Murakami M., Horowitz A., Tang S., Ware J.A., Simons M. Protein kinase C (PKC) delta regulates PKCalpha activity in a Syndecan-4-dependent manner. J. Biol. Chem. 2002, 277:20367-20371.
29. Wang A., Nomura M., Patan S., Ware J.A. Inhibition of protein kinase Calpha prevents endothelial cell migration and vascular tube formation in vitro and myocardial neovascularization in vivo. Circ. Res. 2002, 90:609-616.
30. Zhu J.T., Choi R.C., Li J., Xie H.Q., Bi C.W., Cheung A.W., Dong T.T., Jiang Z.Y., Chen J.J., Tsim K.W. Estrogenic and neuroprotective properties of scutellarin from Erigeron breviscapus: a drug against postmenopausal symptoms and Alzheimer's disease. Planta Med. 2009.